These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19426622)

  • 1. Compatibility of tacrolimus ointment with corticosteroid ointments of varying potencies.
    Pappas L; Kiss A; Levitt J
    J Cutan Med Surg; 2009; 13(3):140-5. PubMed ID: 19426622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compatibility of desoximetasone and tacrolimus.
    Levitt J; Feldman T; Riss I; Leung OT
    J Drugs Dermatol; 2003 Dec; 2(6):640-2. PubMed ID: 14711143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of tacrolimus 0.1% ointment and clobetasol propionate 0.05% ointment in oral lichen planus: a randomized double-blind trial.
    Sonthalia S; Singal A
    Int J Dermatol; 2012 Nov; 51(11):1371-8. PubMed ID: 23067089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of topical tacrolimus 0.1 % in pectin ointment with clobetasol 0.5% ointment in adults with moderate to severe desquamative gingivitis: A 4-week, randomized, double-blind clinical trial.
    Corrocher G; Di Lorenzo G; Mansueto P; Martinelli N; Esposito-Pellitteri M; Gelio S; Lombardo G; Pacor ML
    Clin Ther; 2006 Sep; 28(9):1296-302. PubMed ID: 17062302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality Testing of Tacrolimus Ointment Mixed with Various Type of Ointments or Creams.
    Nakane T; Doi H; Hirohara M; Hamashima H; Inoue Y
    Biol Pharm Bull; 2018; 41(11):1632-1637. PubMed ID: 30381662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desoximetasone 0.25% and tacrolimus 0.1% ointments versus tacrolimus alone in the treatment of atopic dermatitis.
    Hebert AA; Koo J; Fowler J; Berman B; Rosenberg C; Levitt J
    Cutis; 2006 Nov; 78(5):357-63. PubMed ID: 17186796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
    Reitamo S; Ortonne JP; Sand C; Cambazard F; Bieber T; Fölster-Holst R; Vena G; Bos JD; Fabbri P; Groenhoej Larsen C;
    Br J Dermatol; 2005 Jun; 152(6):1282-9. PubMed ID: 15948994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, randomized prospective study evaluating topical clobetasol propionate 0.05% versus topical tacrolimus 0.1% in patients with vulvar lichen sclerosus.
    Funaro D; Lovett A; Leroux N; Powell J
    J Am Acad Dermatol; 2014 Jul; 71(1):84-91. PubMed ID: 24704090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous absorption of drugs used in atopic eczema: pimecrolimus permeates less through skin than corticosteroids and tacrolimus.
    Billich A; Aschauer H; Aszódi A; Stuetz A
    Int J Pharm; 2004 Jan; 269(1):29-35. PubMed ID: 14698574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-blind, randomized controlled trial evaluating the treatment of facial seborrheic dermatitis with hydrocortisone 1% ointment compared with tacrolimus 0.1% ointment in adults.
    Papp KA; Papp A; Dahmer B; Clark CS
    J Am Acad Dermatol; 2012 Jul; 67(1):e11-5. PubMed ID: 22101215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus.
    Pople PV; Singh KK
    Eur J Pharm Biopharm; 2011 Sep; 79(1):82-94. PubMed ID: 21447390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, randomized, placebo-controlled trial of topical tacrolimus 0·1% vs. clobetasol propionate 0·05% in childhood vitiligo.
    Ho N; Pope E; Weinstein M; Greenberg S; Webster C; Krafchik BR
    Br J Dermatol; 2011 Sep; 165(3):626-32. PubMed ID: 21457214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.
    Reitamo S; Harper J; Bos JD; Cambazard F; Bruijnzeel-Koomen C; Valk P; Smith C; Moss C; Dobozy A; Palatsi R;
    Br J Dermatol; 2004 Mar; 150(3):554-62. PubMed ID: 15030341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus ointment causes inflammatory dendritic epidermal cell depletion but no Langerhans cell apoptosis in patients with atopic dermatitis.
    Schuller E; Oppel T; Bornhövd E; Wetzel S; Wollenberg A
    J Allergy Clin Immunol; 2004 Jul; 114(1):137-43. PubMed ID: 15241357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus ointment, an interesting adjunctive therapy for childhood linear IgA bullous dermatosis.
    Dauendorffer JN; Mahé E; Saiag P
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):364-5. PubMed ID: 18269605
    [No Abstract]   [Full Text] [Related]  

  • 16. Tacrolimus ointment in the treatment of chronic cutaneous graft-vs-host disease: a case series of 18 patients.
    Choi CJ; Nghiem P
    Arch Dermatol; 2001 Sep; 137(9):1202-6. PubMed ID: 11559218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative treatment study of topical tacrolimus and clobetasol in oral lichen planus.
    Radfar L; Wild RC; Suresh L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Feb; 105(2):187-93. PubMed ID: 18230389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
    Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
    J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low but detectable serum levels of tacrolimus seen with the use of very dilute, extemporaneously compounded formulations of tacrolimus ointment in the treatment of patients with netherton syndrome.
    Shah KN; Yan AC
    Arch Dermatol; 2006 Oct; 142(10):1362-3. PubMed ID: 17043199
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro release of Tacrolimus from Tacrolimus ointment and its speculated mechanism.
    Yoshida H; Tamura S; Toyoda T; Kado K; Ohnishi N; Ibuki R
    Int J Pharm; 2004 Feb; 270(1-2):55-64. PubMed ID: 14726122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.